Published in J Transplant on October 24, 2011
Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges. Diabetes Metab Syndr Obes (2014) 1.11
Transplantation of betacellulin-transduced islets improves glucose intolerance in diabetic mice. Exp Mol Med (2014) 0.78
The biology of VEGF and its receptors. Nat Med (2003) 32.13
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (1996) 18.47
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med (2000) 18.26
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (1996) 16.92
Vascular-specific growth factors and blood vessel formation. Nature (2000) 14.42
International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43
Five-year follow-up after clinical islet transplantation. Diabetes (2005) 7.86
Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell (1998) 6.44
The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A (2006) 5.41
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med (2000) 5.05
Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes (2004) 4.73
The thrombospondins. Int J Biochem Cell Biol (2004) 3.01
Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci U S A (2001) 2.82
Role of VEGF-A in vascularization of pancreatic islets. Curr Biol (2003) 2.56
Pancreatic islet production of vascular endothelial growth factor--a is essential for islet vascularization, revascularization, and function. Diabetes (2006) 2.53
Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes (2002) 2.28
XIAP: apoptotic brake and promising therapeutic target. Apoptosis (2001) 2.28
Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes (2004) 2.26
Morphological evidence for pancreatic polarity of beta-cell within islets of Langerhans. Diabetes (1988) 2.15
Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes (1996) 2.04
Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol (2005) 2.00
Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes (2004) 1.85
Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes (2002) 1.84
Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts. Diabetes (2005) 1.74
Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Cell Transplant (2009) 1.60
Pancreas transplantation. Lancet (2009) 1.58
Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells. J Clin Invest (1999) 1.45
Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab (1990) 1.44
Graft vascular function after transplantation of pancreatic islets. Diabetologia (2002) 1.42
Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation (2005) 1.36
Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. Diabetes (1999) 1.29
Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes (1989) 1.27
Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes (2007) 1.24
Improved vascular engraftment and graft function after inhibition of the angiostatic factor thrombospondin-1 in mouse pancreatic islets. Diabetes (2008) 1.17
Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver. Diabetes (2004) 1.13
Low revascularization of experimentally transplanted human pancreatic islets. J Clin Endocrinol Metab (2002) 1.12
XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes (2005) 1.12
Low revascularization of human islets when experimentally transplanted into the liver. Transplantation (2009) 1.10
Hepatocyte growth factor enhances engraftment and function of nonhuman primate islets. Diabetes (2008) 1.09
Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus. Arch Surg (2005) 1.09
Angiogenic capacity of endothelial cells in islets of Langerhans. FASEB J (2003) 1.05
Computer-assisted large-scale visualization and quantification of pancreatic islet mass, size distribution and architecture. J Vis Exp (2011) 1.03
Reduced insulin secretion and content in VEGF-a deficient mouse pancreatic islets. Exp Clin Endocrinol Diabetes (2008) 0.99
The effect of medical therapy and islet cell transplantation on diabetic nephropathy: an interim report. Transplantation (2007) 0.97
Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets. Diabetes (2005) 0.97
Thrombospondin-1: an islet endothelial cell signal of importance for β-cell function. Diabetes (2011) 0.96
Treatment with an interleukin-1 receptor antagonist protein prolongs mouse islet allograft survival. Diabetes (1993) 0.96
iNOS gene silencing prevents inflammatory cytokine-induced beta-cell apoptosis. Mol Pharm (2008) 0.91
An odyssey of islet transplantation for therapy of type 1 diabetes. World J Surg (2007) 0.90
Peripheral mobilization of recipient bone marrow-derived endothelial progenitor cells enhances pancreatic islet revascularization and engraftment after intraportal transplantation. Surgery (2003) 0.89
Cell-permeable pentapeptide V5 inhibits apoptosis and enhances insulin secretion, allowing experimental single-donor islet transplantation in mice. Diabetes (2007) 0.89
Expression of pro- and antiapoptotic molecules of the Bcl-2 family in human islets postisolation. Cell Transplant (2011) 0.86
Delivery of hypoxia-inducible VEGF gene to rat islets using polyethylenimine. J Drug Target (2009) 0.78
A comparison of non-viral vectors for gene delivery to pancreatic beta-cells: delivering a hypoxia-inducible vascular endothelial growth factor gene to rat islets. Int J Mol Med (2009) 0.77
SHIP represses the generation of alternatively activated macrophages. Immunity (2005) 7.41
Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med (2007) 3.53
Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes (2012) 2.40
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest (2003) 2.37
Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2003) 2.14
Locus co-occupancy, nucleosome positioning, and H3K4me1 regulate the functionality of FOXA2-, HNF4A-, and PDX1-bound loci in islets and liver. Genome Res (2010) 1.90
Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem (2003) 1.77
Production of functional glucagon-secreting α-cells from human embryonic stem cells. Diabetes (2010) 1.73
The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry (2010) 1.63
Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proc Natl Acad Sci U S A (2006) 1.63
Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Cell Transplant (2009) 1.60
General surgery 2.0: the emergence of acute care surgery in Canada. Can J Surg (2010) 1.58
Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes (2003) 1.49
Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation (2011) 1.46
Islet amyloid polypeptide and type 2 diabetes. Exp Gerontol (2003) 1.33
Cholesterol in islet dysfunction and type 2 diabetes. J Clin Invest (2008) 1.32
Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit fibril thioflavin-T interactions: implications for mechanistic studies of beta-cell death. Biochemistry (2008) 1.32
Identification of a beta-cell-specific HLA class I restricted epitope in type 1 diabetes. Diabetes (2003) 1.30
HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus. Curr Opin Lipidol (2010) 1.29
Loss of both ABCA1 and ABCG1 results in increased disturbances in islet sterol homeostasis, inflammation, and impaired β-cell function. Diabetes (2012) 1.26
Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction. Diabetes Care (2010) 1.26
Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes. Transplantation (2007) 1.23
Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes (2006) 1.21
IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol (2011) 1.20
Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion. Gastroenterology (2010) 1.20
Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes. Diabetes (2006) 1.20
Potential implications of mesenchymal stem cells in cancer therapy. Cancer Lett (2011) 1.19
A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes. Transplantation (2008) 1.18
miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets. Diabetes (2012) 1.16
Proteomic signatures in plasma during early acute renal allograft rejection. Mol Cell Proteomics (2010) 1.14
Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granules. Diabetes (2011) 1.12
Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death. Diabetes (2006) 1.12
Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival. Transplantation (2009) 1.10
Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. J Clin Invest (2011) 1.10
Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus. Arch Surg (2005) 1.09
Canadian consensus conference on the development of training and practice standards in advanced minimally invasive surgery: Edmonton, Alta., Jun. 1, 2007. Can J Surg (2009) 1.08
Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction. Diabetes (2013) 1.08
Whole blood genomic biomarkers of acute cardiac allograft rejection. J Heart Lung Transplant (2009) 1.03
Functional genomic analysis of peripheral blood during early acute renal allograft rejection. Transplantation (2009) 1.03
Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1). Proc Natl Acad Sci U S A (2006) 1.02
Application of in situ ductal perfusion to facilitate isolation of high-quality RNA from mouse pancreas. Biotechniques (2006) 1.02
Voltage-gated Ca(2+) influx and insulin secretion in human and mouse beta-cells are impaired by the mitochondrial Na(+)/Ca(2+) exchange inhibitor CGP-37157. Eur J Pharmacol (2007) 1.01
The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation. J Mol Biol (2010) 1.00
B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation. PLoS One (2012) 1.00
Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis. Surg Endosc (2013) 0.99
Integrin-linked kinase regulates inducible nitric oxide synthase and cyclooxygenase-2 expression in an NF-kappa B-dependent manner. J Biol Chem (2001) 0.99
Canadian Association of General Surgeons statement on endoscopy. Can J Surg (2011) 0.98
The effect of medical therapy and islet cell transplantation on diabetic nephropathy: an interim report. Transplantation (2007) 0.97
Role of beta-cell prohormone convertase (PC)1/3 in processing of pro-islet amyloid polypeptide. Diabetes (2004) 0.97
Strategic faculty recruitment increases research productivity within an academic university division. Can J Surg (2009) 0.97
Effect of glucagon-like peptide-1 (7-37) on beta-cell function after islet transplantation in type 1 diabetes. Diabetes Res Clin Pract (2006) 0.97
Death and dysfunction of transplanted β-cells: lessons learned from type 2 diabetes? Diabetes (2014) 0.96
Early treatment of NOD mice with B7-H4 reduces the incidence of autoimmune diabetes. Diabetes (2011) 0.96
Dynamic assessment of cell viability, proliferation and migration using real time cell analyzer system (RTCA). Cytotechnology (2014) 0.96
Of surgeons and safety checklists. Can J Surg (2010) 0.94
Amyloid inhibitors enhance survival of cultured human islets. Biochim Biophys Acta (2009) 0.94
Thioredoxin-interacting protein promotes islet amyloid polypeptide expression through miR-124a and FoxA2. J Biol Chem (2014) 0.93
Small interfering RNA-mediated suppression of proislet amyloid polypeptide expression inhibits islet amyloid formation and enhances survival of human islets in culture. Diabetes (2008) 0.93
Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway. Cell Transplant (2006) 0.92
Activating the NLRP3 inflammasome using the amyloidogenic peptide IAPP. Methods Mol Biol (2013) 0.92
Molecular signatures of end-stage heart failure. J Card Fail (2011) 0.92
Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal. J Cell Physiol (2011) 0.90
Local expression of indoleamine 2,3 dioxygenase in syngeneic fibroblasts significantly prolongs survival of an engineered three-dimensional islet allograft. Diabetes (2010) 0.90
The X-linked inhibitor of apoptosis protein enhances survival of murine islet allografts. Diabetes (2005) 0.90
Cholesterol in beta-cell dysfunction: the emerging connection between HDL cholesterol and type 2 diabetes. Curr Diab Rep (2010) 0.90
Kinetics and genomic profiling of adult human and mouse β-cell maturation. Islets (2011) 0.90
Advances and challenges in islet transplantation: islet procurement rates and lessons learned from suboptimal islet transplantation. J Transplant (2011) 0.90
An odyssey of islet transplantation for therapy of type 1 diabetes. World J Surg (2007) 0.90
Synthesis of pelorol and analogues: activators of the inositol 5-phosphatase SHIP. Org Lett (2005) 0.89
MSC(TRAIL)-mediated HepG2 cell death in direct and indirect co-cultures. Anticancer Res (2011) 0.89
Reduced progression of diabetic retinopathy after islet cell transplantation compared with intensive medical therapy. Transplantation (2008) 0.88
Role of carboxypeptidase E in processing of pro-islet amyloid polypeptide in {beta}-cells. Endocrinology (2004) 0.88
Tumor necrosis factor-related apoptosis-inducing ligand and CD56 expression in patients with type 1 diabetes mellitus. Pancreas (2005) 0.86
Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine. World J Stem Cells (2011) 0.86
Whole blood biomarkers of acute cardiac allograft rejection: double-crossing the biopsy. Transplantation (2010) 0.86
2004 MacLean-Mueller prize enteral or parenteral nutrition for severe pancreatitis: a randomized controlled trial and health technology assessment. Can J Surg (2005) 0.86
Processing of pro-islet amyloid polypeptide in the constitutive and regulated secretory pathways of beta cells. Mol Endocrinol (2005) 0.86
Islet allograft rejection is independent of toll-like receptor signaling in mice. Transplantation (2009) 0.85
Three-dimensional scaffolds reduce islet amyloid formation and enhance survival and function of cultured human islets. Am J Pathol (2012) 0.85
B7-H4 induces donor-specific tolerance in mouse islet allografts. Cell Transplant (2011) 0.85